Correlation of Dietary Intake and Helicobacter pylori Infection with Multiple Sclerosis, a Case-Control Study in

Sara Kiani1,2, Alireza Vakilian, Zahra Kamiab1,3

  • 1Clinical Research Development Unit, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Qatar Medical Journal
|February 24, 2021
PubMed
Abstract

Insights

This study found lower levels of antibodies to Helicobacter pylori infection (HPI) and certain dietary nutrients in multiple sclerosis (MS) patients. These findings suggest a link between diet, HPI, and MS risk.

Area of Science:

  • Neuroimmunology
  • Nutritional Science
  • Microbiome Research

Background:

  • Multiple sclerosis (MS) is a central nervous system autoimmune disease.
  • Environmental factors, including Helicobacter pylori infection (HPI), may influence MS risk.
  • Dietary intake is a potential modifiable factor in MS.

Purpose of the Study:

  • To investigate the association between serum anti-H. pylori IgG antibody (HPIA) levels and dietary intake in Iranian MS patients.
  • To compare HPIA levels and nutritional intake between MS patients and healthy controls.

Main Methods:

  • A case-control study involving 97 MS patients and 95 controls.
  • Measurement of serum HPIA levels and assessment of dietary intake using a food frequency questionnaire.
  • Statistical analysis including t-tests, Chi-square, Mann-Whitney U test, and correlation analysis.

Main Results:

  • MS patients exhibited significantly lower median serum HPIA levels compared to controls.
  • Reduced median consumption of specific amino acids (glutamic acid, arginine, serine, aspartic acid, alanine, proline) and caffeine was observed in MS patients.
  • Positive correlations between HPIA levels and intake of linoleic acid, lactose, calcium, molybdenum, galactose, leucine, and valine were identified in controls.

Conclusions:

  • Dietary nutrients show correlations with both MS and HPI.
  • Further interdisciplinary research is needed to identify specific foods containing these associated nutrients.

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
322
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
858
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
729
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
459
Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
278
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
501